Literature DB >> 16438674

Memory B cell responses and malaria.

M Wykes1, M F Good.   

Abstract

Malaria is a serious cause of morbidity and mortality in millions of individuals each year. People living in endemic areas build up partial immunity only after repeated attacks of malaria over several years. At this meeting we discussed current knowledge about long-term protection and the challenges we face in the development of an effective malaria vaccine.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16438674     DOI： 10.1111/j.1365-3024.2006.00768.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN： 0141-9838            Impact factor:   2.280


  9 in total

Review 1.  The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Authors:  Ann M Moormann; Cynthia J Snider; Kiprotich Chelimo
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

Review 2.  Malaria Pathogenesis.

Authors:  Danny A Milner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

3.  Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Authors:  K Vaughan; M Blythe; J Greenbaum; Q Zhang; B Peters; D L Doolan; A Sette
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

4.  Maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection.

Authors:  Yan Zhuang; James E Futse; Wendy C Brown; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

5.  Asymptomatic Plasmodium falciparum infection in children is associated with increased auto-antibody production, high IL-10 plasma levels and antibodies to merozoite surface protein 3.

Authors:  Vincent Guiyedi; Christophe Bécavin; Fabien Herbert; Julian Gray; Pierre-André Cazenave; Maryvonne Kombila; Andrea Crisanti; Constantin Fesel; Sylviane Pied
Journal:  Malar J       Date:  2015-04-16       Impact factor: 2.979

Review 6.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

7.  New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women.

Authors:  Freya J I Fowkes; Rose McGready; Nadia J Cross; Mirja Hommel; Julie A Simpson; Salenna R Elliott; Jack S Richards; Kurt Lackovic; Jacher Viladpai-Nguen; David Narum; Takafumi Tsuboi; Robin F Anders; François Nosten; James G Beeson
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

8.  Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.

Authors:  Katherine J Torres; Eva H Clark; Jean N Hernandez; Katherine E Soto-Cornejo; Dionicia Gamboa; OraLee H Branch
Journal:  Malar J       Date:  2008-09-09       Impact factor: 2.979

9.  Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians.

Authors:  Alassane Dicko; David J Diemert; Issaka Sagara; Moussa Sogoba; Mohamed B Niambele; Mahamadoun H Assadou; Ousmane Guindo; Beh Kamate; Mounirou Baby; Mady Sissoko; Elissa M Malkin; Michael P Fay; Mahamadou A Thera; Kazutoyo Miura; Amagana Dolo; Dapa A Diallo; Gregory E Mullen; Carole A Long; Allan Saul; Ogobara Doumbo; Louis H Miller
Journal:  PLoS One       Date:  2007-10-17       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.